LONDON–(BUSINESS WIRE)–The global cancer supportive care market is poised to grow by USD 5.21 billion during 2020-2024, progressing at a CAGR of almost 4% during the forecast period. Request free sample pages
Read the 120-page report with TOC on “Cancer Supportive Care Market Analysis Report by Therapeutic area (Chemotherapy-induced anemia, Chemotherapy-induced neutropenia, Cancer pain, CINV, and Others), Geographic Segmentation (North America, APAC, Europe, South America, and MEA), and the Segment Forecasts, 2020-2024”.
The market is driven by the growing prevalence of cancer cases. In addition, the untapped potential in the developing countries is anticipated to boost the growth of the cancer supportive care market.
The incidence of cancer cases is increasing due to several factors such as lack of physical activity, alcohol and tobacco consumption, and prevalence of obesity. Around 23,310,000 adults aged 18 years and above were detected with cancer in 2018 in the US as per the Centers for Disease Control and Prevention (CDC). Cancer leads to premature death and requires immediate attention and cancer supportive care. As a result, various pharmaceutical companies, research organizations, and government organizations are increasingly making investments in the R&D and treatment of cancer. This is propelling the availability and demand for supportive care therapy drugs. Thus, the growing prevalence of cancer cases is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Cancer Supportive Care Market Companies:
Amgen Inc. operates the business under the Human therapeutics segment. Through this segment, the company develops and delivers innovative human therapeutics. The company offers Neulasta, which is a PEGylated form of human granulocyte CSF.
Baxter International Inc.
Baxter International Inc. offers products through the following business units: Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies, and Other. The company offers REGLAN Injection, which is a metoclopramide injection.
Bayer AG operates under various business segments, namely Pharmaceuticals, Crop science, Consumer health, and Animal health. The company is involved in the development, production, and marketing of prescription products. The company offers Xarelto, which contains rivaroxaban.
Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. offers products through the Pharmaceutical operation business segment. The company is involved in the development, production, and marketing of pharmaceutical drugs. The company offers Naruvein Injection, which is a hydromorphone hydrochloride injection.
GlaxoSmithKline Plc offers products through the following business segments: Pharmaceuticals, Vaccines, and Consumer healthcare. The company is involved in the development and marketing of consumer-preferred and expert-recommended products. The company offers REZONIC, which is a neurokinin 1 receptor antagonist.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Cancer Supportive Care Market Therapeutic area Outlook (Revenue, USD Billion, 2020-2024)
- Chemotherapy-induced anemia
- Chemotherapy-induced neutropenia
- Cancer pain
Cancer Supportive Care Market Geographic segmentation Outlook (Revenue, USD Billion, 2020-2024)
- North America
- South America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health Care Include:
Artificial Blood Substitutes Market – Global Artificial Blood Substitutes Market by product (HBOC and PFBOC) and geography (Asia, Europe, North America, and ROW).
Blood Grouping Reagents Market – Global Blood Grouping Reagents Market by geography (Asia, Europe, North America, and ROW) and end-user (hospitals and blood banks; clinical laboratories; and academic and research institutes).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.